Semi-Annual Consolidated Statement Of Cash Flows

TORII PHARMACEUTICAL CO., LTD. - Filing #7314142

Concept As at
2024-06-30
2024-01-01 to
2024-06-30
As at
2023-12-31
As at
2023-06-30
2023-01-01 to
2023-06-30
As at
2022-12-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
3,707,000,000 JPY
-669,000,000 JPY
Interest and dividends received
250,000,000 JPY
221,000,000 JPY
Interest paid
0 JPY
0 JPY
Income taxes paid
-1,039,000,000 JPY
-1,013,000,000 JPY
Net cash provided by (used in) operating activities
2,918,000,000 JPY
-1,461,000,000 JPY
Cash flows from investing activities
Purchase of securities
-5,999,000,000 JPY
-6,000,000,000 JPY
Purchase of property, plant and equipment
-45,000,000 JPY
-92,000,000 JPY
Proceeds from sale of property, plant and equipment
JPY
0 JPY
Purchase of investment securities
-10,036,000,000 JPY
-10,571,000,000 JPY
Other, net
-917,000,000 JPY
JPY
Net cash provided by (used in) investing activities
-2,512,000,000 JPY
-5,180,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
0 JPY
0 JPY
Dividends paid
-1,967,000,000 JPY
-2,135,000,000 JPY
Net cash provided by (used in) financing activities
-2,152,000,000 JPY
-2,287,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,746,000,000 JPY
-8,930,000,000 JPY
Cash and cash equivalents
32,934,000,000 JPY
34,681,000,000 JPY
36,490,000,000 JPY
45,420,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.